Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer
NCT04271384
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer Stage I
Interventions
COMBINATION_PRODUCT:
nivolumab
Sponsor
Hospital Israelita Albert Einstein